{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:08:43Z","timestamp":1761764923843},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/s11934-006-0020-2","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T14:17:26Z","timestamp":1181225846000},"page":"186-192","source":"Crossref","is-referenced-by-count":3,"title":["Dealing with non-cancerous findings on prostate biopsy"],"prefix":"10.1007","volume":"7","author":[{"given":"Timothy C.","family":"Brand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Thibault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph W.","family":"Basler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, Murray T, Ward E, et al.: Cancer statistics, 2005. Can J Clin 2005, 55:10\u201330.","journal-title":"Can J Clin"},{"key":"20_CR2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.4049\/jimmunol.104.6.1329","volume":"104","author":"RJ Ablin","year":"1970","unstructured":"Ablin RJ, Bronson P, Soanes WA, Witebsky E: Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol 1970, 104:1329\u20131339.","journal-title":"J Immunol"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1530\/jrf.0.0220573","volume":"22","author":"RJ Ablin","year":"1970","unstructured":"Ablin RJ, Soanes WA, Bronson P, Witebsky E: Precipitating antigens of the normal human prostate. J Reprod Fertil 1970, 22:573\u2013574.","journal-title":"J Reprod Fertil"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1001\/jama.252.23.3261","volume":"252","author":"GW Chodak","year":"1984","unstructured":"Chodak GW, Schoenberg HW: Early detection of prostate cancer by routine screening. JAMA 1984, 252:3261\u20133264.","journal-title":"JAMA"},{"key":"20_CR5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0022-5347(17)49828-4","volume":"132","author":"IM Thompson","year":"1984","unstructured":"Thompson IM, Ernst JJ, Gangai MP, Spence CR: Adenocarcinoma of the prostate: results of routine urological screening. J Urol 1984, 132:690\u2013692.","journal-title":"J Urol"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1056\/NEJM199810083391504","volume":"339","author":"MA Eisenberger","year":"1998","unstructured":"Eisenberger MA, Blumenstein BA, Crawford ED, et al.: Bilateral orchiectomy with or without flutamide for metastatic prostate cancer [see comment]. N Engl J Med 1998, 339:1036\u20131042.","journal-title":"N Engl J Med"},{"key":"20_CR7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/003335490411900211","volume":"119","author":"K McDavid","year":"2004","unstructured":"McDavid K, Lee J, Fulton JP, et al.: Prostate cancer incidence and mortality rates and trends in the United States and Canada. Public Health Rep 2004, 119:174\u2013186.","journal-title":"Public Health Rep"},{"key":"20_CR8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/jnci\/dji289","volume":"97","author":"BK Edwards","year":"2005","unstructured":"Edwards BK, Brown ML, Wingo PA, et al.: Annual report to the nation on the status of cancer, 1975\u20132002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005, 97:1407\u20131427.","journal-title":"J Natl Cancer Inst"},{"key":"20_CR9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(17)38664-0","volume":"142","author":"KK Hodge","year":"1989","unstructured":"Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989, 142:71\u201375.","journal-title":"J Urol"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0090-4295(98)00575-5","volume":"53","author":"KL Schwartz","year":"1999","unstructured":"Schwartz KL, Grignon DJ, Sakr WA, Wood DP Jr: Prostate cancer histologic trends in the metropolitan Detroit area, 1982 to 1996. Urology 1999, 53:769\u2013774.","journal-title":"Urology"},{"key":"20_CR11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0022-5347(17)36130-X","volume":"149","author":"JW Colberg","year":"1993","unstructured":"Colberg JW, Smith DS, Catalona WJ: Prevalence and pathological extent of prostate cancer in men with prostate-specific antigen levels of 2.9 to 4.0 ng\/mL. J Urol 1993, 149:507\u2013509.","journal-title":"J Urol"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jama.294.1.66","volume":"294","author":"IM Thompson","year":"2005","unstructured":"Thompson IM, Ankerst DP, Chi C, et al.: Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng\/ml or lower. JAMA 2005, 294:66\u201370.","journal-title":"JAMA"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2004.07.024","volume":"47","author":"B Djavan","year":"2005","unstructured":"Djavan B, Fong YK, Ravery V, et al.: Are repeat biopsies required in men with PSA levels \u2aaf 4 ng\/mL? A Multiinstitutional Prospective European Study. Eur Urol 2005, 47:38\u201344.","journal-title":"Eur Urol"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0022-5347(05)64024-4","volume":"169","author":"BR Matlaga","year":"2003","unstructured":"Matlaga BR, Eskew LA, McCullough DL: Prostate biopsy: indications and technique. J Urol 2003, 169:12\u201319.","journal-title":"J Urol"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0090-4295(02)01625-4","volume":"60","author":"N Fleshner","year":"2002","unstructured":"Fleshner N, Klotz L: Role of \u201csaturation biopsy\u201d in the detection of prostate cancer among difficult diagnostic cases. Urology 2002, 60:93\u201397.","journal-title":"Urology"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/j.1464-410X.2004.05146.x","volume":"94","author":"A Erbersdobler","year":"2004","unstructured":"Erbersdobler A, Augustin H, Schlomm T, Henke RP: Prostate cancers in the transition zone. Part 1: pathological aspects. BJU Int 2004, 94:1221\u20131225.","journal-title":"BJU Int"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1464-410X.2004.05150.x","volume":"94","author":"RK Nam","year":"2004","unstructured":"Nam RK, Toi A, Trachtenberg J, et al.: Variation in patterns of practice in diagnosing screen-detected prostate cancer. BJU Int 2004, 94:1239\u20131244.","journal-title":"BJU Int"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1464-410X.2004.05212.x","volume":"94","author":"TA Stamey","year":"2004","unstructured":"Stamey TA: The era of serum prostate-specific antigen as a marker for biopsy of the prostate and detecting prostate cancer is now over in the USA. BJU Int 2004, 94:963\u2013964.","journal-title":"BJU Int"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00042307-200001000-00002","volume":"10","author":"P Laguna","year":"2000","unstructured":"Laguna P, Alivizatos G: Prostate-specific antigen and benign prostatic hyperplasia. Curr Opin Urol 2000, 10:3\u20138.","journal-title":"Curr Opin Urol"},{"key":"20_CR20","doi-asserted-by":"crossref","unstructured":"Potts JM: The four categories of prostatitis: a practical approach to treatment. Cleve Clin J Med 68:389\u2013390.","DOI":"10.3949\/ccjm.68.5.389"},{"key":"20_CR21","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/S0022-5347(05)67026-7","volume":"164","author":"JM Potts","year":"2000","unstructured":"Potts JM: Prospective identification of National Institutes of Health category-IV prostatitis in men with elevated prostate-specific antigen. J Urol 2000, 164:1550\u20131553.","journal-title":"J Urol"},{"key":"20_CR22","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1159\/000052500","volume":"39","author":"G Karazanashvili","year":"2001","unstructured":"Karazanashvili G, Managadze L: Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4\u201310 ng\/mL and nonsuspicious results of digital rectal examination. Eur Urol 2001, 39:538\u2013543.","journal-title":"Eur Urol"},{"key":"20_CR23","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/S0022-5347(05)65186-5","volume":"167","author":"CB Bozeman","year":"2002","unstructured":"Bozeman CB, Carver BS, Eastham JA, Venable DD: Treatment of chronic prostatitis lowers serum prostatespecific antigen. J Urol 2002, 167:1723\u20131726.","journal-title":"J Urol"},{"key":"20_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.urology.2004.08.060","volume":"64","author":"LH Simardi","year":"2004","unstructured":"Simardi LH, Tobias-MacHado M, Kappaz GT, et al.: Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 2004, 64:1098\u20131101.","journal-title":"Urology"},{"key":"20_CR25","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0022-5347(01)64957-7","volume":"157","author":"J Irani","year":"1997","unstructured":"Irani J, Levillain P, Goujon JM, et al.: Inflammation in benign prostatic hyperplasia: correlation with prostatespecific antigen value. J Urol 1997, 157:1301\u20131303.","journal-title":"J Urol"},{"key":"20_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PH Schatteman","year":"2000","unstructured":"Schatteman PH, Hoekx L, Wyndaele JJ, et al.: Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000, 37:404\u2013412.","journal-title":"Eur Urol"},{"key":"20_CR27","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.urology.2004.07.017","volume":"64","author":"J Kawakami","year":"2004","unstructured":"Kawakami J, Siemens DR, Nickel JC: Prostatitis and prostate cancer: implications for prostate cancer screening. Urology 2004, 64:1075\u20131080. This paper reviewed the evidence for the relationship between prostatic inflammation and changes in PSA.","journal-title":"Urology"},{"key":"20_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00345-003-0333-4","volume":"21","author":"FME Wagenlehner","year":"2003","unstructured":"Wagenlehner FME, Naber KG: Prostatitis: the role of antibiotic treatment. World J Urol 2003, 21:105\u2013108.","journal-title":"World J Urol"},{"key":"20_CR29","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/S0090-4295(00)00776-7","volume":"56","author":"MJ Putzi","year":"2000","unstructured":"Putzi MJ, De Marzo AM: Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology 2000, 56:828\u2013832. This paper explores the pathophysiology of pre-malignant lesions of the prostate.","journal-title":"Urology"},{"key":"20_CR30","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","volume":"155","author":"AM De Marzo","year":"1999","unstructured":"De Marzo AM, Marchi VL, Epstein JI, Nelson WG: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999, 155:1985\u20131992.","journal-title":"Am J Pathol"},{"key":"20_CR31","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0002-9440(10)64132-6","volume":"158","author":"R Shah","year":"2001","unstructured":"Shah R, Mucci NR, Amin A, et al.: Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol 2001, 158:1767\u20131773.","journal-title":"Am J Pathol"},{"key":"20_CR32","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5858\/2003-127-840-IAOTP","volume":"127","author":"A Billis","year":"2003","unstructured":"Billis A, Magna LA: Inflammatory atrophy of the prostate: prevalence and significance. Arch Pathol Lab Med 2003, 127:840\u2013844.","journal-title":"Arch Pathol Lab Med"},{"key":"20_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.urology.2004.10.046","volume":"65","author":"R Postma","year":"2005","unstructured":"Postma R, Schroder FH, van der Kwast TH: Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology 2005, 65:745\u2013749.","journal-title":"Urology"},{"key":"20_CR34","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/S0046-8177(99)90158-2","volume":"30","author":"KA Iczkowski","year":"1999","unstructured":"Iczkowski KA, Cheng L, Qian J, et al.: ASAP is a valid diagnosis: atypical small acinar proliferation [see comment]. Hum Pathol 1999, 30:1403\u20131404.","journal-title":"Hum Pathol"},{"key":"20_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S0090-4295(02)01981-7","volume":"60","author":"KA Iczkowski","year":"2002","unstructured":"Iczkowski KA, Chen HM, Yang XJ, Beach RA: Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy [see comment]. Urology 2002, 60:851\u2013854.","journal-title":"Urology"},{"key":"20_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0022-5347(05)65953-8","volume":"166","author":"JI Epstein","year":"2001","unstructured":"Epstein JI, Potter SR: The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies. J Urol 2001, 166:402\u2013410.","journal-title":"J Urol"},{"key":"20_CR37","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/01.pas.0000168178.48535.0d","volume":"29","author":"C Schlesinger","year":"2005","unstructured":"Schlesinger C, Bostwick DG, Iczkowski KA: High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol 2005, 29:1201\u20131207.","journal-title":"Am J Surg Pathol"},{"key":"20_CR38","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1097\/01.ju.0000134622.54235.93","volume":"172","author":"M Brausi","year":"2004","unstructured":"Brausi M, Castagnetti G, Dotti A, et al.: Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment? J Urol 2004, 172:906\u2013909.","journal-title":"J Urol"},{"key":"20_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0094-0143(02)00189-1","volume":"30","author":"DG Bostwick","year":"2003","unstructured":"Bostwick DG, Qian J, Schlesinger C: Contemporary pathology of prostate cancer. Urol Clin North Am 2003, 30:181\u2013207.","journal-title":"Urol Clin North Am"},{"key":"20_CR40","doi-asserted-by":"crossref","unstructured":"Bostwick DG, Montironi R, Sesterhenn IA: Diagnosis of prostatic intraepithelial neoplasia: Prostate Working Group\/consensus report. Scand J Urol Nephrol Suppl 2000:3\u201310.","DOI":"10.1080\/003655900750169266"},{"key":"20_CR41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.urology.2004.10.010","volume":"65","author":"N Gokden","year":"2005","unstructured":"Gokden N, Roehl KA, Catalona WJ, Humphrey PA: Highgrade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology 2005, 65:538\u2013542.","journal-title":"Urology"},{"key":"20_CR42","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/01.ju.0000148260.69779.c5","volume":"173","author":"CK Moore","year":"2005","unstructured":"Moore CK, Karikehalli S, Nazeer T, et al.: Prognostic significance of high-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. J Urol 2005, 173:70\u201372.","journal-title":"J Urol"},{"key":"20_CR43","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0090-4295(01)01436-4","volume":"58","author":"GK Lefkowitz","year":"2001","unstructured":"Lefkowitz GK, Sidhu GS, Torre P, et al.: Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling? Urology 2001, 58:999\u20131003.","journal-title":"Urology"},{"key":"20_CR44","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.urology.2003.09.066","volume":"63","author":"Y Naya","year":"2004","unstructured":"Naya Y, Ayala AG, Tamboli P, Babaian RJ: Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy? Urology 2004, 63:503\u2013508.","journal-title":"Urology"},{"key":"20_CR45","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1046\/j.1464-410X.2003.04081.x","volume":"91","author":"IF San Francisco","year":"2003","unstructured":"San Francisco IF, Olumi AF, Kao J, et al.: Clinical management of prostatic intraepithelial neoplasia as diagnosed by extended needle biopsies. BJU Int 2003, 91:350\u2013354.","journal-title":"BJU Int"},{"key":"20_CR46","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0344-0338(11)80965-9","volume":"191","author":"WA Sakr","year":"1995","unstructured":"Sakr WA, Grignon DJ, Haas GP, et al.: Epidemiology of high-grade prostatic intraepithelial neoplasia. Pathol Res Pract 1995, 191:838\u2013841.","journal-title":"Pathol Res Pract"},{"key":"20_CR47","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.urology.2005.05.006","volume":"66","author":"V Scattoni","year":"2005","unstructured":"Scattoni V, Roscigno M, Freschi M, et al.: Predictors of prostate cancer after initial diagnosis of atypical small acinar proliferation at 10 to 12 core biopsies. Urology 2005, 66:1043\u20131047.","journal-title":"Urology"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-006-0020-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0020-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-006-0020-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:40:50Z","timestamp":1683877250000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-006-0020-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1007\/s11934-006-0020-2","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}